Effects of fibrin and α2-Antiplasmin on plasminogen activation by staphylokinase

American Journal of Hematology

Volumn 53, Issue 3, 1996, Pages 151-157

  Okada, Kiyotaka ^a   Ueshima, Shigeru ^a   Takaishi, Tomoaki ^a   Yuasa, Haruyuki ^a   Fukao, Hideharu ^a   Matsuo, Osamu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 antiplasmin; Fibrin; Plasminogen; Plasminogen activation; Staphylokinase

Indexed keywords

ALPHA 2 ANTIPLASMIN; AMINOCAPROIC ACID; FIBRIN; PLASMINOGEN; STAPHYLOKINASE; ANTIPLASMIN; AUR PROTEIN, STAPHYLOCOCCUS AUREUS; FIBRINOGEN; METALLOPROTEINASE; PEPTIDE FRAGMENT; PLASMIN;

ARTICLE; ENZYME KINETICS; HUMAN; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; BIOSYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; KINETICS; MACROMOLECULE; METABOLISM; PROTEIN BINDING;

6-AMINOCAPROIC ACID; ANTIPLASMIN; ENZYME ACTIVATION; FIBRIN; FIBRINOGEN; HUMANS; KINETICS; MACROMOLECULAR SUBSTANCES; METALLOENDOPEPTIDASES; PEPTIDE FRAGMENTS; PLASMIN; PLASMINOGEN; PROTEIN BINDING;

EID: 0029661824     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199611)53:3<151::AID-AJH1>3.0.CO;2-Y     Document Type: Article

References (38)

1. Collen D: On the regulation and control of fibrinolysis. Thromb Haemost 43:77, 1980.
2. Collen D, Lijnen HR: Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78:3114, 1991.
3. Summaria L, Robbins KC, Barlow GH: Dissociation of the equimolar human plasminogen-streptokinase complex. J Biol Chem 246:2136, 1971.
4. Lijnen HR, Van Hoef B, De Cock F, Okada K, Ueshima S, Matsuo O, Collen D: On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem 266:11826, 1991.
5. Lack CH: Staphylokinase: An activator of plasma protease. Nature 161:559, 1948.
6. Collen D, Schlott B, Engelborghs Y, Van Hoef B, Hartmann M, Lijien HR, Behnke D: On the mechanism of the activation of human plasminogen by recombinant staphylokinase. J Biol Chem 268:8284, 1993.
7. McClintock DK, Bell PH: The mechanism of activation of human plasminogen by streptokinase. Biochem Biophys Res Commun 43:694, 1971.
8. Lijnen HR, van Hoef B, Collen D: Interaction of staphylokinase with different molecular forms of plasminogen. Eur J Biochem 211:91, 1993.
9. Okada K, Yuasa H, Hagiya Y, Fukao H, Ueshima S, Matsuo O: Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin. Thromb Res 76:181, 1994.
10. Shibata H, Nagaoka M, Sakai M, Sawada H, Watanabe T, Yokokuwa T: Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex. J Biochem 115:738, 1994.
11. 2-antiplasmin and fibrin. Biochim Biophys Acta 1118:144, 1992.
12. 2-antiplasmin. J Biol Chem 268:9816, 1993.
13. 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex. Thromb Res 76:211, 1994.
14. 2-plasmin inhibitor. Biochem Biophys Res Commum 162:830, 1989.
15. Matsuo O, Okada K, Fukao H, Tomioka Y, Ueshima S, Watanuki M, Sakai M: Thrombolytic properties of staphylokinase. Blood 76:925, 1990.
16. 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma. Blood 82:1175, 1993.
17. Lijnen HR, Stassen JM, Vanlinthout I, Fukao H, Okada K, Matsuo O, Collen D: Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis. Thromb Haemost 66:468, 1991.
18. Collen D, De Cock F, Stassen J-M: Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboons. Circulation 87:996, 1993.
19. Declerck PJ, Vanderschueren S, Billiet J, Moreau H, Collen D: Prevalence and induction of circulating antibodies against recombinant staphylokinase. Thromb Haemost 71:129, 1994.
20. Vanderschueren S, Stassen JM, Collen D: On the immunogenicity of recombinant staphylokinase in patients and in animal models. Thromb Haemost 72:297, 1994.
21. Collen D, Van de Werf F: Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction. Circulation 87:1850, 1993.
22. Vanderschueren S, Barrions L, Kerinchai P, Van den Heuvel P, Hermans L, Vrolix M, De Man F, Benit E, Muyldermans L, Collen D, Van de Werf F; for the STAR Trial Group: A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. Circulation 92:2044, 1995.
23. Sako T: Overproduction of staphylokinase in Escherichia coli and its characterization. Eur J Biochem 149:557, 1985.
24. Deutsch DG, Mertz ET: Plasminogen: Purification from human plasma by affinity chromatography. Science 170:1095, 1970.
25. Sottrup-Jensen L, Claeys H, Zaydel M, Petersen TE, Magnusson S: The primary structure of human plasminogen. Isolation of two lysine-binding fragments and one "Mini-"plasminogen (MW, 38,000) by elastase-catalyzed-specific limited proteolysis. In Davidson JF, Rowan MM, Desnoyers PC (eds): "Progress in Chemical Fibrinolysis and Thrombolysis," Vol. 3:191. New York: Raven Press, 1978.
26. 2-antiplasmin and in fibrinogen. Biochem Biophys Acta 579:142, 1979.
27. Nieuwenhuizen W, Verheigen JH, Vermond A, Chang GTT: Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2. Biochem Biophys Acta 755:531, 1983.
28. Yonekawa O, Vermond A, Nieuwenhuizen W: Localization of a new site in fibrin, involved in the acceleration of t-PA mediated activation of plasminogen. Thromb Haemost 62:194, 1989.
29. Marder VJ, Budzynski AZ, Barlow GH: Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin. Biochim Biophys Acta 427:1, 1976.
30. Olexa SA, Budzynski AZ: Primary soluble plasmic degradation product of human cross-linked fibrin. Isolation and stoichiometry of the (DD)E complex. Biochemistry 18:991, 1979.
31. Friberger P: Chromogenic peptide substrates: Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems. Scand J Clin Lab Invest 42:9, 1982.
32. Schielen WJD, Voskuilen M, Tesser GI, Nieuwenhuizen W: The sequence Aα(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies. Proc Natl Acad Sci USA 86:8951, 1989.
33. Schielen WJD, Adams HPHM, van Leuven K, Voskuilen M, Tesser GI, Nieuwenhuizen W: The sequence γ-(312-324) is a fibrin-specific epitope. Blood 77:2169, 1991.
34. Hasan AAK, Chang WS, Budzynski AZ: Binding of fibrin fragments to one-chain and two-chain tissue-type plasminogen activator. Blood 79:2313, 1992.
35. Ellis V, Scully MF, Kakkar VV: Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study. J Biol Chem 262:1498, 1987.
36. Hoylaerts M, Rijken DC, Lijnen HR, Collen D: Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 257:2912, 1982.
37. Mangel WF, Lin B, Ramakrishnan V: Characterization of an extremely large, ligand-induced conformational change in plasminogen. Science 248:69, 1990.
38. McCance SG, Castellino FJ: Contributions of individual kringle domains towards maintenance of the chloride-induced tight conformation of human glutamic acid-1 plasminogen. Biochemistry 34:9581, 1995.